S-1 induces meibomian gland dysfunction.
Matsumoto
Yukihiro
Y
Dogru
Murat
M
Sato
Enrique Adan
EA
Ibrahim
Osama M A
OM
Tatematsu
Yukako
Y
Ogawa
Yoko
Y
Tsubota
Kazuo
K
D000368:Aged; D000964:Antimetabolites, Antineoplastic / Q000009:adverse effects*; D003316:Corneal Diseases / Q000139:chemically induced; D004338:Drug Combinations; D015352:Dry Eye Syndromes / Q000139:chemically induced; D005141:Eyelid Diseases / Q000139:chemically induced* / Q000175:diagnosis; D005260:Female; D006801:Humans; D008297:Male; D008537:Meibomian Glands / Q000187:drug effects* / Q000473:pathology; D018613:Microscopy, Confocal; D008875:Middle Aged; D009369:Neoplasms / Q000188:drug therapy; D010094:Oxonic Acid / Q000009:adverse effects*; D005641:Tegafur / Q000009:adverse effects*
D000964:Antimetabolites, Antineoplastic; D004338:Drug Combinations; C079198:S 1 (combination); D005641:Tegafur; D010094:Oxonic Acid